Annual Cash & Cash Equivalents
$12.07 M
-$5.30 M-30.50%
March 31, 2024
Summary
- As of February 8, 2025, SXTC annual cash & cash equivalents is $12.07 million, with the most recent change of -$5.30 million (-30.50%) on March 31, 2024.
- During the last 3 years, SXTC annual cash & cash equivalents has fallen by -$1.26 million (-9.47%).
- SXTC annual cash & cash equivalents is now -30.50% below its all-time high of $17.37 million, reached on March 31, 2023.
Performance
SXTC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$12.07 M
+$605.30 K+5.28%
March 31, 2024
Summary
- As of February 8, 2025, SXTC quarterly cash and cash equivalents is $12.07 million, with the most recent change of +$605.30 thousand (+5.28%) on March 31, 2024.
- Over the past year, SXTC quarterly cash and cash equivalents has dropped by -$5.30 million (-30.50%).
- SXTC quarterly cash and cash equivalents is now -30.50% below its all-time high of $17.37 million, reached on March 31, 2023.
Performance
SXTC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SXTC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.5% | -30.5% |
| 3 y3 years | -9.5% | -30.5% |
| 5 y5 years | +32.2% | -30.5% |
SXTC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.5% | at low | -30.5% | >+9999.0% |
| 5 y | 5-year | -30.5% | +65.6% | -30.5% | >+9999.0% |
| alltime | all time | -30.5% | >+9999.0% | -30.5% | >+9999.0% |
China SXT Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $12.07 M(-30.5%) | $12.07 M(+5.3%) |
| Sep 2023 | - | $11.46 M(-34.0%) |
| Mar 2023 | $17.37 M(+11.9%) | $17.37 M(+482.6%) |
| Sep 2022 | - | $2.98 M(-80.8%) |
| Mar 2022 | $15.52 M(+16.4%) | $15.52 M(>+9900.0%) |
| Sep 2021 | - | $31.30 K(-99.8%) |
| Mar 2021 | $13.33 M | $13.33 M(+28.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $10.35 M(+42.1%) |
| Mar 2020 | $7.29 M(-20.2%) | $7.29 M(-11.6%) |
| Sep 2019 | - | $8.25 M(-9.7%) |
| Mar 2019 | $9.13 M(+1529.6%) | $9.13 M(+4107.7%) |
| Sep 2018 | - | $217.00 K(-61.3%) |
| Mar 2018 | $560.30 K(+754.1%) | $560.30 K |
| Mar 2017 | $65.60 K | - |
FAQ
- What is China SXT Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is China SXT Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is China SXT Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of SXTC is $12.07 M
What is the all time high annual cash & cash equivalents for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high annual cash & cash equivalents is $17.37 M
What is China SXT Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, SXTC annual cash & cash equivalents has changed by -$5.30 M (-30.50%)
What is China SXT Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SXTC is $12.07 M
What is the all time high quarterly cash and cash equivalents for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high quarterly cash and cash equivalents is $17.37 M
What is China SXT Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, SXTC quarterly cash and cash equivalents has changed by -$5.30 M (-30.50%)